Equities researchers at Brookline Capital Management issued their Q1 2025 earnings per share estimates for OS Therapies in a research report issued to clients and investors on Wednesday, April 2nd.

Analysts at HC Wainwright issued their FY2028 earnings per share estimates for shares of Cytosorbents in a research note issued to investors on Thursday, April 3rd. HC Wainwright analyst S. Lee ...

Trump Weakens U.S. Cyberdefenses at a Moment of Rising Danger The firing of the head of the N.S.A. was only the latest move to erode fortifications against cyberattacks, especially those targeting ...